Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Home Access Health submits PMA application to FDA for home-use HIV test.

This article was originally published in The Tan Sheet

Executive Summary

HOME ACCESS HEALTH SUBMITS PMA APPLICATION TO FDA FOR HOME-USE HIV TEST and requests an expedited review, the Chicago-based start-up announced June 1. Home Access Health Corp., formerly known as Anonymous Test Services, said it filed the premarket approval application following the mid-March completion of multi-center Phase III clinical trials involving more than 1,200 subjects. Home Access Health's PMA for an over-the-counter HIV test is the third such filing, joining the Johnson & Johnson subsidiary Direct Access Diagnostics' Confide and ChemTrak's HIV-1 Home Check tests at FDA.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083887

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel